Abraham Avigdor
- Specjalizacja: Hematolog
- 35 lat doświadczenia
- Języki:English, Hebrew
- Konsultacje online: dostępne
- Miejsce pracy: Izrael, Ramat Gan, Centrum Medyczne Sheba
- Director of the Institute of Hematology; founder and president of the Israeli Lymphoma Working Group; author of 130+ scientific publications.
Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.
He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.
He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.
Dr Abraham Avigdor oferuje konsultacje online
Usługi lekarza
- Chemioterapia
- Przeszczep szpiku kostnego
- Terapia komórkami CAR-T
- Chemioterapia przy białaczce
- Plazmafereza
- Chemioterapia w przypadku chłoniaka
- Haploidentyczny przeszczep szpiku kostnego
- Przeszczepienie szpiku kostnego allogeniczne od dawcy spokrewnionego
- Allogeniczna transplantacja szpiku kostnego od niespokrewnionego dawcy
- Afereza terapeutyczna
- Plazmafereza DFPP
- Wymiana plazmy
- Selektywna afereza
- Ultradźwięk
- TK (tomografia komputerowa)
- Biopsja
- Badanie krwi na obecność markerów nowotworowych
- Immunohistochemia
- Biopsja szpiku kostnego
- Konsultacja online z onkologiem
- MRI jednego przekroju
Jak Państwo oceniają naszą usługę?
Kwalifikacje
Dr. Abraham Avigdor, MD
Director, Institute of Hematology & Co-Director, Hematology and Bone Marrow Transplantation Division – Sheba Medical Center
Global Leader in Lymphoma, CAR-T Therapy & Advanced Hemato-Oncology
Dr. Abraham Avigdor is a highly distinguished hemato-oncologist with over 35 years of experience, specializing in the treatment of lymphomas, multiple myeloma, and complex blood cancers.
As Director of the Institute of Hematology at Sheba Medical Center, he leads one of the region’s most advanced programs in bone marrow transplantation and cellular therapies, including CAR-T treatment.
Areas of Expertise
- Lymphoma (Primary Focus)
Expert in all types of lymphoma, including Hodgkin and Non-Hodgkin lymphoma- Advanced Hemato-Oncology Treatments
-
- CAR-T Cell Therapy – pioneer in integrating CAR-T into lymphoma and myeloma treatment
- Bone Marrow Transplantation – both autologous and allogeneic transplants
- Stem Cell Therapies and advanced cellular treatments
- Multiple Myeloma
Personalized and innovative treatment strategies for complex cases - Precision Diagnostics
Use of PET/CT imaging as a prognostic tool and integration of biological and immunological therapies
Clinical Leadership & Innovation
Dr. Avigdor is internationally recognized for advancing modern lymphoma care, focusing on:
- Integration of immunotherapy and targeted treatments
- Development of innovative treatment protocols
- Personalized, data-driven patient management
His work has helped shape the use of CAR-T therapy as a standard option in advanced hematologic cancers.
International Research & Collaboration
Dr. Avigdor collaborates with leading global research groups, including:
- LYSA (France) – Lymphoma Study Association
- European Mantle Cell Lymphoma Network (EMCL)
- International PET Study Groups in Lymphoma & Myeloma
He has authored 130+ scientific publications, contributing significantly to advancements in lymphoma treatment and cellular therapies.
Leadership & Academic Roles
- Director, Institute of Hematology, Sheba Medical Center
- Co-Director, Hematology & Bone Marrow Transplant Division
- Founder & President, Israeli Lymphoma Working Group
- Former Chairman, Israeli Lymphoma Study Group (2011–2018)
- Senior Lecturer, Tel Aviv University
- Member, National Hematology Consultation Committee (Health Basket)
Education & Training
- MD, Ben-Gurion University of the Negev
- Residency in Internal Medicine & Hematology, Sheba Medical Center
- Postdoctoral Fellowship in Stem Cell Biology, Weizmann Institute of Science
Awards & Recognition
- Knesset Prize for excellence in medical studies
- Israeli Ministry of Health Award for outstanding physician performance
- Sackler Prize for Research Excellence, Tel Aviv University
Patient-Centered Approach
Dr. Avigdor combines decades of experience, global leadership, and cutting-edge therapies to provide highly personalized care for patients with complex blood cancers.
His approach focuses on:
- Access to the most advanced treatments worldwide
- Multidisciplinary care and precise diagnosis
- Improving survival while maintaining quality of life
A Leading Name in Modern Hemato-Oncology
Through his leadership in CAR-T therapy, bone marrow transplantation, and lymphoma research, Dr. Avigdor offers patients access to one of the most advanced and comprehensive blood cancer programs globally.
Mogą Państwa również zainteresować
Płatność i nagrody
Państwo nie płacą za nasze usługi
Płatność jest dokonywana bezpośrednio w klinice lub na jej oficjalne konto bankowe.
Niektóre kliniki mogą wymagać wpłaty depozytu zgodnie ze swoją polityką.
Proszę płacić w ratach.
Proszę zapraszać znajomych do Bookimed i otrzymywać nagrody.